Skip to content

Efficacy and Safety of 570/590 nm Yellow Light Combined with Red Light and Infrared LED in Treating Facial Skin Photoaging Under the Same Electric Power

Efficacy and Safety of 570/590 nm Yellow Light Combined with Red Light and Infrared LED in Treating Facial Skin Photoaging Under the Same Electric Power: A Single-Center, Randomized Controlled, Exploratory Study.

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101437
Enrollment
Unknown
Registered
2025-04-24
Start date
2025-03-12
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

skin photoage

Interventions

:Composed of yellow LED with a wavelength of 590nm, red LED with a wavelength of 620nm, and infrared LED with a wavelength of 850nm, with an electrical power of 16W and an energy of 5.04J/cm ^ 2.
:Composed of a 570nm yellow LED, a 620nm red LED, and an 850nm infrared LED, with an electrical power of 16W and an energy of 6.39J/cm ^ 2

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. In line with the photoaging skin grading: Fitzpatrick Skin classification is type III to IV; 2. Age 30-65 years, and willing to receive the study treatment; 3. Facial photoaging overall score (GSP score) is 3-4 points;

Exclusion criteria

Exclusion criteria: 1. Face with other skin diseases or other factors that affect the treatment effect; 2. Nearly half a year of internal treatment of related beauty treatment (such as laser, RF, photon, Botox injection, hyaluronic acid injection, chemical stripping, etc.); 3. Be sensitive to light or take photosensitive drugs in nearly half a year (such as retinoic acid, hydroquinone, etc.); 4. Patients with endocrine diseases or serious chronic diseases affecting the skin physiological conditions (such as anemia, systemic lupus erythematosus, hepatic and renal dysfunction, etc.); 5. Women born in pregnancy or lactation; 6. Scar constitution; 7. History of mental illness; 8. History of other systemic diseases; 9. Expectations are too high;

Design outcomes

Primary

MeasureTime frame
The proportion of the wrinkle score that has decreased by at least 15% from the baseline;;

Secondary

MeasureTime frame
The proportion of the melanin score that has decreased by at least 5% from the baseline;;The proportion of the brown spot score that has decreased by at least 5% from the baseline;;The proportion of the GSP score that has decreased by at least 1 point from the baseline;;

Countries

China

Contacts

Public ContactZhibin Zhang

The First Affiliated Hospital of Nanchang University

zzbpf0624@163.com+86 18720227613

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026